偽性副甲状腺機能低下症
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/04/07 11:48:49」(JST)
[Wiki en表示]
Pseudohypoparathyroidism |
Classification and external resources |
Specialty |
Endocrinology |
ICD-10 |
E20.1 |
ICD-9 |
275.49 |
OMIM |
103580 603233 203330 |
DiseasesDB |
10835 10851 |
MedlinePlus |
000364 |
eMedicine |
med/1940 |
MeSH |
D011547 |
Pseudohypoparathyroidism is a condition associated primarily with resistance to the parathyroid hormone.[1] Those with the condition have a low serum calcium and high phosphate, but the parathyroid hormone level (PTH) is actually appropriately high (due to the low level of calcium in the blood). Its pathogenesis has been linked to dysfunctional G Proteins (in particular, Gs alpha subunit). The condition is extremely rare, with an estimated overall prevalence of 7.2/1,000,000 or approximately 1/140000.
Contents
- 1 Types
- 2 Related conditions
- 3 Presentation and differential
- 4 Biochemical Findings
- 5 See also
- 6 References
Types
Types include:
Type |
Description |
OMIM |
Gene |
Type 1a |
Has a characteristic phenotypic appearance (Albright's hereditary osteodystrophy), including short fourth and fifth metacarpals and a rounded facies. It is most likely an autosomal dominant disorder.[2] It is also associated with thyroid stimulating hormone resistance.[3] |
103580 |
GNAS1 |
Type 1b |
Lacks the physical appearance of type 1a, but is biochemically similar.[4] It is associated with a methylation defect.[5][6] |
603233 |
GNAS1, STX16 |
Type 2 |
Also lacks the physical appearance of type 1a.[7] Since the genetic defect in type 2 is further down the signalling pathway than in type 1, there is a normal cAMP response to PTH stimulation despite the inherent abnormality in calcium regulation. |
203330 |
? |
While biochemically similar, type 1 and 2 disease may be distinguished by the differing urinary excretion of cyclic AMP in response to exogenous PTH.
Some sources also refer to a "type 1c".[8]
Related conditions
The term pseudopseudohypoparathyroidism is used to describe a condition where the individual has the phenotypic appearance of pseudohypoparathyroidism type 1a, but is biochemically normal.
Condition |
Appearance |
PTH levels |
Calcitriol |
Calcium |
Phosphates |
Imprinting |
Hypoparathyroidism |
Normal |
Low |
Low |
Low |
High |
Not applicable |
Pseudohypoparathyroidism |
Type 1A |
Skeletal defects |
High |
Low |
Low |
High |
Gene defect from mother (GNAS1) |
Type 1B |
Normal |
High |
Low |
Low |
High |
Gene defect from mother (GNAS1 and STX16) |
Type 2 |
Normal |
High |
Low |
Low |
High |
? |
Pseudopseudohypoparathyroidism |
Skeletal defects |
Normal |
Normal |
Normal[9] |
Normal |
gene defect from father |
Presentation and differential
Patients may present with features of hypocalcaemia including carpo-pedal muscular spasms, cramping, tetany, and if the calcium deficit is severe, generalized seizures. IQ is typically mildly depressed or unaffected. Additional characteristics include short stature, obesity, developmental delay, and calcification of the basal ganglia in the deep white matter of the brain.
Type 1a Pseudohypoparathyroidism is clinically manifest by bone resorption with blunting of the fourth and fifth knuckles of the hand, most notable when the dorsum of the hand is viewed in closed fist position. This presentation is known as 'knuckle knuckle dimple dimple' sign (Archibald's Sign). This is as opposed to Turner syndrome which is characterized by blunting of only the fourth knuckle, and Down's syndrome, which is associated with a hypoplastic middle phalanx.
Biochemical Findings
- hypocalcemia
- hyperphosphatemia
- elevated parathyroid hormone (hyperparathyroidism)
- Supressed calcitriol levels [10]
See also
- Hypoparathyroidism
- Pseudopseudohypoparathyroidism
- Hyperparathyroidism
- Rickets
- Hypervitaminosis D
References
- ^ Bastepe M (2008). "The GNAS locus and pseudohypoparathyroidism". Adv. Exp. Med. Biol. 626: 27–40. doi:10.1007/978-0-387-77576-0_3. PMID 18372789.
- ^ Online 'Mendelian Inheritance in Man' (OMIM) 103580
- ^ de Nanclares GP, Fernández-Rebollo E, Santin I et al. (June 2007). "Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy". J. Clin. Endocrinol. Metab. 92 (6): 2370–3. doi:10.1210/jc.2006-2287. PMID 17405843.
- ^ Online 'Mendelian Inheritance in Man' (OMIM) 603233
- ^ Laspa E, Bastepe M, Jüppner H, Tsatsoulis A (December 2004). "Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance". J. Clin. Endocrinol. Metab. 89 (12): 5942–7. doi:10.1210/jc.2004-0249. PMID 15579741.
- ^ Fröhlich LF, Bastepe M, Ozturk D, Abu-Zahra H, Jüppner H (June 2007). "Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16". Endocrinology 148 (6): 2925–35. doi:10.1210/en.2006-1298. PMID 17317779.
- ^ Online 'Mendelian Inheritance in Man' (OMIM) 203330
- ^ Aldred MA (May 2006). "Genetics of pseudohypoparathyroidism types Ia and Ic". J. Pediatr. Endocrinol. Metab. 19 (Suppl 2): 635–40. PMID 16789628.
- ^ Shahid Hussain; Sharif Aaron Latif; Adrian Hall (1 July 2010). Rapid Review of Radiology. Manson Publishing. pp. 262–. ISBN 978-1-84076-120-7. Retrieved 30 October 2010.
- ^ Levine, Michael. "Pseudohypoparathyroidism: A Variation on the Theme of Hypoparathyroidism".
Inborn error of metal metabolism (E83, 275)
|
|
Transition metal |
Fe |
high: |
- Primary iron overload disorder: Hemochromatosis/HFE1
- Juvenile/HFE2
- HFE3
- African iron overload/HFE4
- Aceruloplasminemia
- Atransferrinemia
- Hemosiderosis
|
|
deficiency: |
|
|
|
Cu |
high: |
- Copper toxicity
- Wilson's disease
|
|
deficiency: |
- Copper deficiency
- Menkes disease/Occipital horn syndrome
|
|
|
Zn |
high: |
|
|
deficiency: |
- Acrodermatitis enteropathica
|
|
|
|
Electrolyte |
Na+ and K+ |
- see Template:Water-electrolyte imbalance and acid-base imbalance
|
|
PO43− |
high: |
|
|
deficiency: |
- Hypophosphatemia
- alkaline phosphatase
|
|
|
Mg2+ |
|
|
Ca2+ |
high: |
- Hypercalcaemia
- Milk-alkali syndrome (Burnett's)
- Calcinosis (Calciphylaxis, Calcinosis cutis)
- Calcification (Metastatic calcification, Dystrophic calcification)
- Familial hypocalciuric hypercalcemia
|
|
deficiency: |
- Hypocalcaemia
- Osteomalacia
- Pseudohypoparathyroidism (Albright's hereditary osteodystrophy)
- Pseudopseudohypoparathyroidism
|
|
|
|
|
|
Description |
- Vitamins
- Cofactors
- Metal metabolism
- Fats
- metabolism
- intermediates
- lipoproteins
- Sugars
- Glycolysis
- Glycogenesis and glycogenolysis
- Fructose and galactose
|
|
Disease |
- Vitamins
- Carbohydrate
- Lipid
- Metals
- Other
- Symptoms and signs
|
|
Treatment |
- Drugs
- Vitamins
- Mineral supplements
|
|
|
Cell surface receptor deficiencies
|
|
G protein-coupled receptor
(including hormone) |
Class A |
- TSHR (Congenital hypothyroidism 1)
- LHCGR (Male-limited precocious puberty)
- FSHR (XX gonadal dysgenesis)
- EDNRB (ABCD syndrome, Waardenburg syndrome 4a, Hirschsprung's disease 2)
- AVPR2 (Nephrogenic diabetes insipidus 1)
- PTGER2 (Aspirin-induced asthma)
|
|
Class B |
- PTH1R (Jansen's metaphyseal chondrodysplasia)
|
|
Class C |
- CASR (Familial hypocalciuric hypercalcemia)
|
|
Class F |
- FZD4 (Familial exudative vitreoretinopathy 1)
|
|
|
Enzyme-linked receptor
(including
growth factor) |
RTK |
- ROR2 (Robinow syndrome)
- FGFR1 (Pfeiffer syndrome, KAL2 Kallmann syndrome)
- FGFR2 (Apert syndrome, Antley–Bixler syndrome, Pfeiffer syndrome, Crouzon syndrome, Jackson–Weiss syndrome)
- FGFR3 (Achondroplasia, Hypochondroplasia, Thanatophoric dysplasia, Muenke syndrome)
- INSR (Donohue syndrome
- Rabson–Mendenhall syndrome)
- NTRK1 (Congenital insensitivity to pain with anhidrosis)
- KIT (KIT Piebaldism, Gastrointestinal stromal tumor)
|
|
STPK |
- AMHR2 (Persistent Müllerian duct syndrome II)
- TGF beta receptors: Endoglin/Alk-1/SMAD4 (Hereditary hemorrhagic telangiectasia)
- TGFBR1/TGFBR2 (Loeys-Dietz syndrome)
|
|
GC |
- GUCY2D (Leber's congenital amaurosis 1)
|
|
|
JAK-STAT |
- Type I cytokine receptor: GH (Laron syndrome)
- CSF2RA (Surfactant metabolism dysfunction 4)
- MPL (Congenital amegakaryocytic thrombocytopenia)
|
|
TNF receptor |
- TNFRSF1A (TNF receptor associated periodic syndrome)
- TNFRSF13B (Selective immunoglobulin A deficiency 2)
- TNFRSF5 (Hyper-IgM syndrome type 3)
- TNFRSF13C (CVID4)
- TNFRSF13B (CVID2)
- TNFRSF6 (Autoimmune lymphoproliferative syndrome 1A)
|
|
Lipid receptor |
- LRP: LRP2 (Donnai–Barrow syndrome)
- LRP4 (Cenani–Lenz syndactylism)
- LRP5 (Worth syndrome, Familial exudative vitreoretinopathy 4, Osteopetrosis 1)
- LDLR (LDLR Familial hypercholesterolemia)
|
|
Other/ungrouped |
- Immunoglobulin superfamily: AGM3, 6
- Integrin: LAD1
- Glanzmann's thrombasthenia
- Junctional epidermolysis bullosa with pyloric atresia
EDAR (EDAR Hypohidrotic ectodermal dysplasia)
- PTCH1 (Nevoid basal cell carcinoma syndrome)
- BMPR1A (BMPR1A Juvenile polyposis syndrome)
- IL2RG (X-linked severe combined immunodeficiency)
|
|
- See also
- cell surface receptors
|
|
Description |
- Structure
- Organelles
- Peroxisome
- Cytoskeleton
- Centrosome
- Epithelia
- Cilia
- Mitochondria
- Membranes
- Membrane transport
- ion channels
- vesicular transport
- solute carrier
- ABC transporters
- ATPase
- oxidoreduction-driven
|
|
Disease |
- Structural
- Peroxisome
- Cytoskeleton
- Cilia
- Mitochondria
- Nucleus
- Scleroprotein
- DNA/RNA
- Replication and repair
- Transcription factor
- Transcription
- Translation
- Membrane
- Channelopathy
- Solute carrier
- ATPase
- ABC transporters
- Other
- Extracellular ligands
- Cell surface receptors
- Intracellular signalling
- Vesicular transport
- Pore-forming toxins
|
|
|
Non-Mendelian inheritance: genomic imprinting
|
|
Chromosome 15 |
- Angelman syndrome ♀ / Prader-Willi syndrome ♂
|
|
Chromosome 11 |
- Beckwith–Wiedemann syndrome ♀ / Silver–Russell syndrome ♂
|
|
|
|
|
Chromosome 20 |
- Pseudohypoparathyroidism ♀ / Pseudopseudohypoparathyroidism ♂
|
|
Chromosome 6 |
- Transient neonatal diabetes mellitus
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Pseudohypoparathyroidism with Hashimoto's thyroiditis and Turner syndrome: a case report.
- Zeng WH1, Xu JJ, Jia MY, Ren YZ.
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.Gynecol Endocrinol.2014 Jun 10:1-3. [Epub ahead of print]
- Abstract Objective: To report the case of an individual with PHP, Turner syndrome and Hashimoto's thyroiditis. Case: A 16-year-old girl was referred to our hospital with chief complaint of short stature. She presented with round chubby facies, short neck, obesity and short stature. Radiography indic
- PMID 24915162
- A novel mutation in pseudohypoparathyroidism type 1a in a Chinese woman and her son with hypocalcaemia.
- Tam VH1, Chen SP2, Mak CM2, Fung LM1, Lee CY3, Chan AY2.
- Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine.Hong Kong Med J.2014 Jun;20(3):258-60. doi: 10.12809/hkmj134025.
- Pseudohypoparathyroidism is a rare genetic disorder characterised by end-organ resistance to parathyroid hormone due to a defect of the guanine nucleotide-binding protein alpha that simulates activity of the polypeptide 1 (GNAS) gene. Patients with type 1a pseudohypoparathyroidism display different
- PMID 24914079
- Gradual development of brachydactyly in pseudohypoparathyroidism.
- Virágh K1, Tőke J, Sallai A, Jakab Z, Rácz K, Tóth M.
- The Journal of clinical endocrinology and metabolism.J Clin Endocrinol Metab.2014 Jun;99(6):1945-6. doi: 10.1210/jc.2014-1674. Epub 2014 Mar 31.
- PMID 24684469
Japanese Journal
- Pseudohypoparathyroidism Type II in a Woman with a History of Thyroid Surgery
- Murakami Takaaki,Nambu Takuo,Morimoto Yuki,Matsuda Yuki,Matsuo Koji,Yonemitsu Shin,Muro Seiji,Oki Shogo
- Internal Medicine 53(7), 743-747, 2014
- … We herein describe the case of a woman with pseudohypoparathyroidism (PHP) type II. …
- NAID 130003392748
- 副甲状腺機能低下症および偽性副甲状腺機能低下症 (特集 知っておきたい先天性・遺伝性内分泌疾患)
- Neuromuscular symptoms in a patient with familial pseudohypoparathyroidism type Ib diagnosed by methylation-specific multiplex ligation-dependent probe amplification
- NAGASAKI Keisuke,TSUCHIYA Shuichi,SAITOH Akihiko,OGATA Tsutomu,FUKAMI Maki
- Endocrine journal 60(2), 231-236, 2013-02-01
- NAID 10031156746
Related Links
- I have had pseudohypoparathyroidism.com all my life but it wasn't detected or diagnosed untill my early teen years. Pseudohypoparathyroidism has been with me a long time and I hope I can answer some of your questions with this ...
- Pseudohypoparathyroidism. Pseudohypoparathyroidism (PHP) is a heterogeneous group of disorders characterized by hypocalcemia, hyperphosphatemia, increased serum concentration of parathyroid hormone (PTH ... ...
Related Pictures
★リンクテーブル★
[★]
- 英
- pseudohypoparathyroidism PHP
- 同
- 偽性上皮小体機能低下症、仮性副甲状腺機能低下症
- 関
- 副甲状腺機能低下症
概念
- 副甲状腺ホルモン(PTH)の欠乏が見られないにもかかわらず、症候的には副甲状腺機能低下症を呈する疾患。
- PTHに対する標的臓器(腎臓、骨)に反応が見られない(不応性を呈する)ことが原因である。
- 原発性・続発性の副甲状腺機能低下症と区別するために「偽性」を冠してオールブライト(Albright F)らが命名した(1942)と言われている。
検査所見
- 血液検査:PTH低値、低カルシウム血症、高リン血症
症状
副甲状腺機能低下症に共通した症状(YN.D51)
偽性副甲状腺機能低下症に特有の症状(YN.D51)
- 知能低下
- 低身長、肥満、円形顔貌
- 全身けいれん発作、四肢筋のひきつれ
検査
血液生化学
ホルモン
参考
- http://www.nurs.or.jp/~academy/igaku/s3/s32332.htm
- 2. Pseudohypoparathyroidism - pubmed health
- http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001403/
- http://www.hypoparathyroidism.org.uk/details05.asp?id=-1990863324
- http://www.endotext.org/parathyroid/parathy
[★]
参考
[★]
偽性偽性副甲状腺機能低下症
[★]
偽性偽性副甲状腺機能低下症